Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Tumor, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04441099
What this trial is testing

NBE-002 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced CancerTriple Negative Breast Cancer
NBE-Therapeutics AG 12
Not applicableLooking for participantsNCT03889899
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 30
Not applicableStudy completedNCT06202599
What this trial is testing

Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance

Who this might be right for
Bone SarcomaSoft Tissue SarcomaRefractory Tumor
Peking University People's Hospital 124
Early research (Phase 1)Looking for participantsNCT06980116
What this trial is testing

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

Who this might be right for
Relapsed or Refractory B-cell MalignanciesChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Follicular Lymphoma (FL)+4 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 85
Large-scale testing (Phase 3)Study completedNCT05198934
What this trial is testing

Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation

Who this might be right for
Colorectal Cancer (CRC)
Amgen 160
Early research (Phase 1)Study completedNCT00020111
What this trial is testing

Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Active Not RecruitingNCT01933932
What this trial is testing

Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC

Who this might be right for
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
AstraZeneca 510
Testing effectiveness (Phase 2)Study completedNCT00000687
What this trial is testing

Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Testing effectiveness (Phase 2)Study completedNCT02945800
What this trial is testing

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

Who this might be right for
OsteosarcomaEwing SarcomaRhabdomyosarcoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 59
Not applicableUnknownNCT00757263
What this trial is testing

Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom

Who this might be right for
Ovarian Cancer
Cancer Research UK 2,000
Not applicableLooking for participantsNCT06674811
What this trial is testing

Biomarkers of Resiliency In Childhood Cancer Surgery

Who this might be right for
Pediatric CancerNeuroblastomaSarcoma+10 more
Mayo Clinic 40
Not applicableLooking for participantsNCT07188532
What this trial is testing

Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial

Who this might be right for
Ewing SarcomaRound Cell Sarcoma With EWSR1-non-ETS Fusion
Mayo Clinic 141
Testing effectiveness (Phase 2)Study completedNCT00002804
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 43
Early research (Phase 1)Looking for participantsNCT04282044
What this trial is testing

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Who this might be right for
Solid Tumor, AdultTriple Negative Breast CancerColorectal Cancer+6 more
BioEclipse Therapeutics 60
Testing effectiveness (Phase 2)Study completedNCT00407433
What this trial is testing

Clinical Studies of Gemcitabine-Oxaliplatin

Who this might be right for
MedulloblastomaCentral Nervous System TumorsNeuroblastoma+1 more
Gustave Roussy, Cancer Campus, Grand Paris 156
Not applicableLooking for participantsNCT05910307
What this trial is testing

Synovial Sarcoma Registry / Biospecimen Repository

Who this might be right for
Synovial Sarcoma
Children's Hospital of Philadelphia 1,000
Very early researchLooking for participantsNCT07436364
What this trial is testing

Application of Contrast-enhanced Ultrasound in Monitoring Soft Tissue Sarcoma Response to Neoadjuvant Radiotherapy

Who this might be right for
Soft Tissue Sarcoma
Thomas Jefferson University 10
Testing effectiveness (Phase 2)Study completedNCT01185964
What this trial is testing

Olaratumab in Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
Eli Lilly and Company 148
Testing effectiveness (Phase 2)Study completedNCT00867529
What this trial is testing

Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma

Who this might be right for
B-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+35 more
Fred Hutchinson Cancer Center 63
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Next Page